
Sign up to save your podcasts
Or


Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
By Forbes India3.6
1313 ratings
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India

11,099 Listeners

296 Listeners

386 Listeners

405 Listeners

157 Listeners

14 Listeners

57 Listeners

684 Listeners

89 Listeners

39 Listeners

40 Listeners

5 Listeners

15 Listeners

11 Listeners

10 Listeners